News

1 to 9 of 23 results

Teva gets positive UK judgment in case against AstraZeneca

Teva gets positive UK judgment in case against AstraZeneca

03-09-2014

A positive judgment has been given by the UK High Court in support of Israeli generic drug giant Teva…

AstraZenecaDuoResp SpiromaxGenericsLegalPatentsRespiratory and PulmonarySymbicortTeva Pharmaceutical IndustriesUK

Positive CHMP opinion for Teva’s DuoResp Spiromax for asthma and COPD

22-02-2014

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive…

AstraZenecaDuoResp SpiromaxPharmaceuticalRegulationRespiratory and PulmonarySymbicortTeva Pharmaceutical Industries

News briefs: US Crestor patent upheld; Pfizer animal health plans; Teva South Korea JV

17-12-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZ) said on Friday that the US Court of Appeals for the Federal…

Asia-PacificAstraZenecaCrestorGenericsHandok PharmaceuticalsLegalMergers & AcquisitionsNorth AmericaPatentsPfizerPharmaceuticalTeva Pharmaceutical IndustriesZoetis

FDA approves first generic copies of Merck & Co's Singulair; and Pulmicort Respules

06-08-2012

The US Food and Drug Administration on Friday approved the first generic versions of Singulair (montelukast…

AstraZenecaGenericsMerck & CoMylan LaboratoriesNorth AmericaPulmicort RespulesRegulationRespiratory and PulmonarySandozSingulairTeva Pharmaceutical IndustriesWatson Pharmaceuticals

Indian, Israeli and US drugmakers leap into US market with generic Seroquel

29-03-2012

Less than a week after a US District Court for the District of Columbia issued an opinion and order in…

AstraZenecaDr Reddy's LaboratoriesGenericsLupinMarkets & MarketingMylan LaboratoriesNeurologicalNorth AmericaQuetiapine FumarateSeroquelSun Pharmaceutical IndustriesTeva Pharmaceutical Industries

AstraZeneca looses out on European Nexium-related patent decision; downgraded by BarCap

13-06-2011

The European Patent Office has invalidated one of the patents - EP1020461 - on Anglo-Swedish drug major…

AstraZenecaBrilintaCardio-vascularCrestorFinancialGastro-intestinalsMarkets & MarketingNexiumPatentsPharmaceuticalTeva Pharmaceutical Industries

AstraZeneca unit MedImmune in-licenses anti-inflammatory MAb from Amgen; latter’s Sensipar patent upheld

10-01-2011

In a second deal in the space of a month for MedImmune, a US unit of Anglo-Swedish drug major AstraZeneca…

AmgenAnti-Arthritics/RheumaticsAstraZenecaBarr LaboratoriesLicensingMedImmuneOncologyPatentsPharmaceuticalSensiparTeva Pharmaceutical Industries

1 to 9 of 23 results

COMPANY SPOTLIGHT

Menarini

Back to top